The Salience team is driven by one common goal: patient remission. We’re actively working to reduce the rate of suicide in the US, by changing the delivery model of behavioral health. Our proven track record, patient-inspired approach and highly skilled team offer uniquely better treatment options for patients suffering from mood disorders. We are research-driven, using objective diagnostic tools and advanced scientific training to connect our patients back to their lives.
Over 70% of our patients report a positive response, which we credit to our innovative, persistent, and compassionate approach. Salience treatment coordinators are extensively trained in outcome intervention, customized care plans, safety protocols and the latest science in TMS Therapy and depression. Our team is the most experienced in Texas, having performed over 100,000 TMS treatments. Because our goal is to help you along your path to remission, our patient advocates answer all your questions, navigate insurance, and assist you with billing options so that you can reconnect to what matters.
Salience TMS Founder Tim Kriske was approached in 2011 by leaders in the TMS community to help them grow TMS treatment across the U.S. Their explanation of neuroplasticity reminded him of his brother who was a US Marine and suffered a traumatic brain injury. After many doctors couldn’t assist him, one neurologist took a chance and helped him regain mobility and speech. The theory was that his brain rerouted his neurocircuitry, enabling him to recover through the science of neuroplasticity. Inspired by the neurologist who took a chance with his brother, Tim decided that every person deserves an opportunity to work with the most clinically current doctors and to understand all of their available treatment options.
We began our TMS clinic with one doctor and one employee in 2011. Since then, we’ve rapidly grown, utilizing the research and insights from treatments to continually refine and enhance our protocols to improve our patient outcomes. Our focus is on connecting patients to a better healthcare experience. With our team today and partnerships with the leading TMS research providers around the globe, we continue to refine our work with a patient inspired approach, developing enhanced treatment protocols and delivering superior results.
Brett CormierChief Executive Officer
Kathy BlackburnChief Operating Officer
Dr. Nancy DonachieChief Medical Officer
John KriskeChief Reporting Officer
Katherine KriskeVice President of Business Development
Joseph KriskeDirector of Clinical Research and Development
Holly JonesDirector of CBO
Andrew CampisiDirector of Marketing
Cameron DennisPatient Advocacy Director
Andrew BlackburnDirector of Business Development
Dr. Madhukar Trivedi is a professor in the department of psychiatry at UT Southwestern Medical Center. He serves as chief of the division of mood disorders and the founding director of the Center for Depression Research and Clinical Care, where he holds the Betty Jo Hay Distinguished Chair in Mental Health and the Julie K. Hersh Chair for Depression Research and Clinical Care. As an internationally recognized translational researcher, he focuses on developing and validating biosignatures of depression. He also conducts research on pharmacological, psychosocial, and nonpharmacological treatments for depression. He has been a principal investigator on numerous translational research projects as well as clinical trials; authored more than 500 peer-reviewed scholarly articles, numerous abstracts, and book chapters; and delivered more than 200 invited lectures. Dr. Trivedi was listed by Thomson Reuters’ World’s Most Influential Scientific Minds as one of the nation’s most highly cited researchers in psychiatry in 2014, 2015, and 2017.
Dr. Jonathan Downar is the co-director of the MRI-Guided rTMS Clinic at University Health Network, and also holds the position of scientist at the Toronto Western Research Institute. He completed a BSc in biology at McGill University, followed by a PhD in neuroimaging at the University of Toronto with Dr. Karen Davis, before obtaining his medical degree from the University of Calgary in 2005. He returned to Toronto for his psychiatry residency training, during which he completed a research fellowship in neuroeconomics with Dr. Read Montague at Baylor College of Medicine. Over the last five years, rTMS at UHN has expanded to four stimulation suites and 18 full-time staff. As of October 2015, the clinic has received over 1,600 community referrals and delivered over 20,000 sessions of stimulation. The clinic currently sees some 40-60 patients a day, making it one of the busiest in North America.
Dr. David Hagedorn is experienced in clinical health psychology and neuropsychology and serves as an international neuroscience and biofeedback research consultant and instructor. He is an assistant professor of military and emergency medicine and family medicine at Uniformed Services University of the Health Sciences School of Medicine. Dr. Hagedorn has master’s degrees in both applied behavior analysis and clinical psychology, with a graduate specialty in gerontology. He also has a doctoral degree in clinical psychology, with an additional health psychology doctoral certificate and postdoctoral training in neuropsychology. Dr. Hagedorn is board certified by the Biofeedback Certification International Alliance as an electroencephalography biofeedback practitioner. As a recognized leader in the clinical neuroscience field, he has with expertise in EEG and ERP acquisition, qEEG analysis, and brain computer interface (BCI) and portable peripheral biofeedback methods.
After a lifelong battle with depression and several medications that only half-way helped, I had very little hope left in finding a successful treatment of any kind. But after some hesitation, I finally decided to commit to TMS treatment.— Tracey C.